Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1983 February; 76(2): 144–148.
PMCID: PMC1438671

Chemotherapy and the adult gonad: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (678K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bergquist C, Nillius SJ, Wide L. Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist. Contraception. 1979 May;19(5):497–506. [PubMed]
  • Bonadonna G, Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med. 1981 Jan 1;304(1):10–15. [PubMed]
  • Brook CG, Dombey S. Induction of puberty: long-term treatment with high-dose LHRH. Clin Endocrinol (Oxf) 1979 Jul;11(1):81–87. [PubMed]
  • Bulbrook RD, Moore JW, Clark GM, Wang DY, Tong D, Hayward JL. Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer. Eur J Cancer. 1978 Dec;14(12):1369–1375. [PubMed]
  • Chapman RM, Sutcliffe SB, Malpas JS. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA. 1979 Oct 26;242(17):1877–1881. [PubMed]
  • Chapman RM, Sutcliffe SB, Malpas JS. Male gonadal dysfunction in Hodgkin's disease. A prospective study. JAMA. 1981 Apr 3;245(13):1323–1328. [PubMed]
  • Chapman RM, Sutcliffe SB, Rees LH, Edwards CR, Malpas JS. Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet. 1979 Feb 10;1(8111):285–289. [PubMed]
  • Cheviakoff S, Calamera JC, Morgenfeld M, Mancini RE. Recovery of spermatogenesis in patients with lymphoma after treatment with chlorambucil. J Reprod Fertil. 1973 Apr;33(1):155–157. [PubMed]
  • Etteldorf JN, West CD, Pitcock JA, Williams DL. Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr. 1976 Feb;88(2):206–212. [PubMed]
  • Fairley KF, Barrie JU, Johnson W. Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet. 1972 Mar 11;1(7750):568–569. [PubMed]
  • Fisher B, Sherman B, Rockette H, Redmond C, Margolese R, Fisher ER. 1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers. Cancer. 1979 Sep;44(3):847–857. [PubMed]
  • Fraser HM, Laird NC, Blakeley DM. Decreased pituitary responsiveness and inhibition of the luteinizing hormone surge and ovulation in the stumptailed monkey (Macaca arctoides) by chronic treatment with an agonist of luteinizing hormone-releasing hormone. Endocrinology. 1980 Feb;106(2):452–457. [PubMed]
  • Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet. 1981 May 23;1(8230):1132–1134. [PubMed]
  • Himelstein-Braw R, Peters H, Faber M. Morphological study of the ovaries of leukaemic children. Br J Cancer. 1978 Jul;38(1):82–87. [PMC free article] [PubMed]
  • Jacobs C, Portlock CS, Rosenberg SA. Prednisone in MOPP chemotherapy for Hodgkin's disease. Br Med J. 1976 Dec 18;2(6050):1469–1471. [PMC free article] [PubMed]
  • Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 1977 Apr;39(4):1403–1409. [PubMed]
  • LANDING BH, GOLDIN A, NOE HA. Testicular lesions in mice following parenteral administration of nitrogen mustards. Cancer. 1949 Nov;2(6):1075–illust. [PubMed]
  • Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N Engl J Med. 1981 Sep 17;305(12):663–667. [PubMed]
  • LOUIS J, LIMARZI LR, BEST WR. Treatment of chronic granulocytic leukemia with myleran. AMA Arch Intern Med. 1956 Mar;97(3):299–308. [PubMed]
  • Mancini RE, Lavieri JC, Muller F, Andrada JA, Saraceni DJ. Effect of prednisolone upon normal and pathologic human spermatogenesis. Fertil Steril. 1966 Jul-Aug;17(4):500–513. [PubMed]
  • Nillius SJ, Bergquist C, Wide L. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control? Contraception. 1978 Jun;17(6):537–545. [PubMed]
  • Richter P, Calamera JC, Morgenfeld MC, Kierszenbaum AL, Lavieri JC, Mancini RE. Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer. 1970 May;25(5):1026–1030. [PubMed]
  • Roeser HP, Stocks AE, Smith AJ. Testicular damage due to cytotoxic drugs and recovery after cessation of therapy. Aust N Z J Med. 1978 Jun;8(3):250–254. [PubMed]
  • Rose DP, Davis TE. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Res. 1980 Nov;40(11):4043–4047. [PubMed]
  • Samaan NA, deAsis DN, Jr, Buzdar AU, Blumenschein GR. Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy. Cancer. 1978 Jun;41(6):2084–2087. [PubMed]
  • Sanger WG, Armitage JO, Schmidt MA. Feasibility of semen cryopreservation in patients with malignant disease. JAMA. 1980 Aug 22;244(8):789–790. [PubMed]
  • Schulz KD, Schmidt-Rhode P, Weymar P, Künzig HJ, Geiger W. The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer. Arch Gynecol. 1979;227(4):293–301. [PubMed]
  • Shalet SM, Hann IM, Lendon M, Morris Jones PH, Beardwell CG. Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child. 1981 Apr;56(4):275–278. [PMC free article] [PubMed]
  • Sherins RJ, DeVita VT., Jr Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. Ann Intern Med. 1973 Aug;79(2):216–220. [PubMed]
  • Sieber SM, Correa P, Dalgard DW, Adamson RH. Carcinogenic and other adverse effects of procarbazine in nonhuman primates. Cancer Res. 1978 Jul;38(7):2125–2134. [PubMed]
  • Siris ES, Leventhal BG, Vaitukaitis JL. Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med. 1976 May 20;294(21):1143–1146. [PubMed]
  • Sobrinho LG, Levine RA, DeConti RC. Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents. Am J Obstet Gynecol. 1971 Jan 1;109(1):135–139. [PubMed]
  • Tcholakian RK, de la Cruz A, Chowdhury M, Steinberger A, Coy DH, Schally AV. Unusual anti-reproductive properties of the analog [d-Leu6,des-Gly-NH2(10)]-luteinizing hormone-releasing hormone ethylamide in male rats. Fertil Steril. 1978 Nov;30(5):600–603. [PubMed]
  • Vermeulen A, Suy E, Rubens R. Effect of prolactin on plasma DHEA (s) levels. J Clin Endocrinol Metab. 1977 Jun;44(6):1222–1225. [PubMed]
  • Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophosphamide-induced ovarian failure. N Engl J Med. 1973 Nov 29;289(22):1159–1162. [PubMed]
  • Waxman JH, Terry YA, Wrigley PF, Malpas JS, Rees LH, Besser GM, Lister TA. Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy. Br Med J (Clin Res Ed) 1982 Dec 4;285(6355):1612–1613. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press